Eagle Pharmaceuticals Buy Hold or Sell Recommendation

EGRXDelisted Stock  USD 1.99  0.02  1.02%   
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Eagle Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Eagle Pharmaceuticals given historical horizon and risk tolerance towards Eagle Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Eagle Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
In addition, we conduct extensive research on individual companies such as Eagle and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Eagle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Eagle Pharmaceuticals Buy or Sell Advice

The Eagle recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eagle Pharmaceuticals. Macroaxis does not own or have any residual interests in Eagle Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eagle Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Eagle PharmaceuticalsBuy Eagle Pharmaceuticals
Not Rated
For the selected time horizon Eagle Pharmaceuticals has a Risk Adjusted Performance of (0.13), Jensen Alpha of (1.12), Total Risk Alpha of (2.26) and Treynor Ratio of 1.87
We provide trade advice to complement the prevailing expert consensus on Eagle Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Eagle Pharmaceuticals is not overpriced, please confirm all Eagle Pharmaceuticals fundamentals, including its number of shares shorted, current ratio, working capital, as well as the relationship between the ebitda and target price . Please also check Eagle Pharmaceuticals price to earning to verify your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Eagle Pharmaceuticals Trading Alerts and Improvement Suggestions

Eagle Pharmaceuticals is not yet fully synchronised with the market data
Eagle Pharmaceuticals generated a negative expected return over the last 90 days
Eagle Pharmaceuticals has high historical volatility and very poor performance
Eagle Pharmaceuticals may become a speculative penny stock
Eagle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 316.61 M. Net Loss for the year was (2.67 M) with profit before overhead, payroll, taxes, and interest of 221.67 M.
Over 77.0% of the company shares are held by institutions such as insurance companies

Eagle Pharmaceuticals Returns Distribution Density

The distribution of Eagle Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Eagle Pharmaceuticals' future price movements. The chart of the probability distribution of Eagle Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Eagle Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eagle Pharmaceuticals returns is essential to provide solid investment advice for Eagle Pharmaceuticals.
Mean Return
-1.19
Value At Risk
-8.24
Potential Upside
9.24
Standard Deviation
6.74
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eagle Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 735 shares by Brian Cahill of Eagle Pharmaceuticals at 5.13 subject to Rule 16b-3 [view details]

Eagle Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Eagle . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Eagle Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Eagle Pharmaceuticals? Buying financial instruments such as Eagle Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Eagle Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Eagle Pink Sheet

If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios